Posted on 10/26/2021 8:47:38 AM PDT by UMCRevMom@aol.com
U.S. researchers – including those advising the federal government on COVID-19 vaccination policy and those funded by the National Institutes of Health – attended a Chinese Communist Party virology conference featuring scientists from China’s military and the Wuhan Institute of Virology.
Shi pictured on Bottom Left.
Shi, whose controversial work focuses on the manipulation of bat coronaviruses for human infection, delivered an opening keynote address at the conference on “the impact of 2019 new coronavirus mutation on virus pathogenicity and immune escape.” Seven additional speakers at the conference were from the Wuhan Institute of Virology, believed by many to be the source of COVID-19.
The Wuhan Institute of Virology’s scientific journal, Virologica Sinica, was also a sponsor of the conference.
In addition to a heavy Chinese Communist Party presence, American researchers, including those working for the federal government, were also in attendance.
Stanley Perlman, who serves on the Vaccines and Related Biological Products Advisory Committee (VRBPAC), which is charged with advising the Food and Drug Administration (FDA) on the approval of COVID-19 vaccines, attended the conference and delivered a presentation entitled “Animal Models of COVID-19.”
Perlman, who has advocated for the authorization of COVID-19 booster shots, also serves on a Centers for Disease Control and Prevention (CDC) committee tasked with planning COVID-19 vaccine allocation.
Perlman has also been a strong promoter of the “natural origins” theory, branding the possibility that the virus was engineered in the Chinese Communist Party-run Wuhan Institute of Virology as “impossible.” He was also a member on the now-disbanded Lancet medical journal’s COVID-19 origins investigation committee and signatory on the infamous Lancet COVID-19 statement, which prematurely debunked the virus tracing its origins to the Wuhan lab.
Also speaking at the conference was Zheng Zhiming, who serves as a Senior Investigator at the U.S. National Institutes of Health (NIH). He received the NIH’s 2010 Award of Merit along with a Director’s Award from the NIH’s National Cancer Institute.
Also addressing the conference were several Chinese military-linked researchers from institutes including the Chinese People’s Liberation Army (PLA) Naval Medical University, the Military Medical Academy, and the PLA Academy of Military Sciences.
Qin Chengfeng, a PLA Academy of Military Sciences research fellow, lectured on the “adaptive mutation of the new coronavirus: from human to mouse.” The unearthed presentation follows increased scrutiny over the manipulation coronavirus strains to increase lethality – through risky “gain-of-function” research – with mice designed to mimic human cells.
“The purpose of the conference is to discuss the main scientific issues and research hotspots of virology, exchange the latest research results and research ideas, display new methods, new technologies and new products for the diagnosis and prevention of viral diseases, and promote the exchange between Chinese scholars and international counterparts,” explains the event’s promotional website before emphasizing that “the exchanges and cooperation between the two countries have promoted the development of virology research in China.”
I know this guy who’s a high-ranking Air Force officer. He tells me that the Wuhan virus was most definitely a military project that got out of hand. It was no innocent civilian research project.
Whistleblowers and other insiders warn of even more virulent bioweapons to come. And don’t forget the Chinese are buying (and stealing, of course) all the DNA data they can get their unwashed hands on. This should be interesting . . .
The fact that they are still engaged with China surprises m,e NOT.
Ping
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.